Profile picture

Associate Professor David R Van Wagoner

Cleveland Clinic, Cleveland (United States of America)
Membership: ESC Professional Member EHRA Member
Follow
Logo ESC

Contributor content

Dysregulated Ca<sup>2+</sup> cycling in atrial fibrillation
Journal
Dysregulated Ca<sup>2+</sup> cycling in atrial fibrillation
4 April 2023
Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?
Journal
Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?
1 March 2013
Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model
Journal
Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model
30 November 2010
Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality
Journal
Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality
18 November 2010
Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?
Journal
Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?
30 June 2008
Evaluating the impact of atrial dilatation on atrial calcium cycling
Journal
Evaluating the impact of atrial dilatation on atrial calcium cycling
7 April 2008

ESC 365 is supported by